Teva accounting chief Amir Weiss sells 17,289 shares

Available on EDGAR 11/12/2026 - 04:11 PM EST Accepted by SEC EDGAR 11/12/2026 - 04:10 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

TEVA Chief Accounting Officer Amir Weiss exercised options covering 7,755 ordinary shares on November 9, 2026, at a $34.70 exercise price, acquiring 7,755 ordinary shares. He also sold 17,289 ordinary shares across three transactions that day: 662 at $43.15 per share, 7,093 at a weighted-average $43.0349, and 9,534 at a weighted-average $43.0289. No Rule 10b5-1 plan is reported.

Insider Trade Summary

Exercise and sale activity reported; no spread calculated

Exercise and Sale 5 txns

Insider Weiss Amir

Role Chief Accounting Officer

Sold 17,289 shs ($744K)

Approx. gross sale proceeds $744K

Approx. exercise cost $269K

Type	Security	Shares	Price	Value
Exercise	Stock Options (right to buy) F3	7,755	$0.00	$0.00
Exercise	Ordinary Shares	7,755	$34.70	$269K
Sale	Ordinary Shares	662	$43.15	$29K
Sale	Ordinary Shares F1	7,093	$43.0349	$305K
Sale	Ordinary Shares F2	9,534	$43.0289	$410K

Holdings After Transaction: Stock Options (right to buy) — 0 options (Direct); Ordinary Shares — 3,537 shares (Direct)

Footnotes (3)

1. F1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.02 to $43.05, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
2. F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.025 to $43.04, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
3. F3. Stock options were granted on March 3, 2017, with 1,938 vested on each of March 3, 2018, March 3, 2019 and March 3, 2020, and 1,941 vested on March 3, 2021.

Key Figures

Options exercised: 7,755 options Exercise price: $34.70 per share Ordinary shares acquired: 7,755 shares +4 more

7 metrics

Options exercised 7,755 options November 9, 2026

Exercise price $34.70 per share Options exercised on November 9, 2026

Ordinary shares acquired 7,755 shares On exercise of options on November 9, 2026

Ordinary shares sold 17,289 shares Across three transactions on November 9, 2026

Sale price $43.15 per share 662 ordinary shares sold on November 9, 2026

Weighted-average sale price $43.0349 per share 7,093 ordinary shares; transactions ranged from $43.02 to $43.05

Weighted-average sale price $43.0289 per share 9,534 ordinary shares; transactions ranged from $43.025 to $43.04

Key Terms

weighted average price, exercise price, vested

3 terms

weighted average price financial

"The price reported in Column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

exercise price financial

"conversion_or_exercise_price: 34.7000"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vested technical

"1,938 vested on each of March 3, 2018, March 3, 2019 and March 3, 2020"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many TEVA shares did Chief Accounting Officer Amir Weiss sell?

Amir Weiss sold 17,289 ordinary shares in three transactions on November 9, 2026: 662 at $43.15 per share, 7,093 at a weighted-average $43.0349 per share, and 9,534 at a weighted-average $43.0289 per share. The weighted-average sales had disclosed ranges of $43.02 to $43.05 and $43.025 to $43.04, respectively. No Rule 10b5-1 plan is reported.

When did Amir Weiss's TEVA stock options vest?

The options were granted on March 3, 2017. 1,938 options vested on each of March 3, 2018, March 3, 2019, and March 3, 2020, and 1,941 vested on March 3, 2021.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Weiss Amir

(Last) (First) (Middle)

C/O TEVA PHARMACEUTICAL INDUSTRIES LTD.

124 DVORA HANEVI'A ST.,

(Street)

TEL AVIV 6944020

(City) (State) (Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
TEVA PHARMACEUTICAL INDUSTRIES LTD [ TEVA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Accounting Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	11/09/2026		M		7,755	A	$34.7	20,826	D
Ordinary Shares	11/09/2026		S		662	D	$43.15	20,164	D
Ordinary Shares	11/09/2026		S		7,093	D	$43.0349(1)	13,071	D
Ordinary Shares	11/09/2026		S		9,534	D	$43.0289(2)	3,537	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (right to buy)	$34.7	11/09/2026		M			7,755	(3)	03/03/2027	Ordinary Shares	7,755	$0	0	D

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.02 to $43.05, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.025 to $43.04, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.

3. Stock options were granted on March 3, 2017, with 1,938 vested on each of March 3, 2018, March 3, 2019 and March 3, 2020, and 1,941 vested on March 3, 2021.

	/s/ Dov Bergwerk as attorney-in-fact for Amir Weiss	11/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)